首页> 中文期刊> 《山东医药》 >血浆纤维蛋白原检测在短暂性脑缺血发作预后判断中的应用

血浆纤维蛋白原检测在短暂性脑缺血发作预后判断中的应用

         

摘要

Objective To explore the predictive value of the level of plasma fibrinogen ( FIB ) for the prognosis of pa-tients with transient ischemic attack ( TIA) .Methods 132 patients with acute TIA in hospitalization were enrolled .These patients were divided into low (0~3 points, 46 patients), mederate (4~5 points, 70 patients) and high (6~7 points, 16 patients) risk groups according to their ABCD2 scores.The levels of FIB were detected by using SYSTEX CA-7000 Au-tomated Blood Coagulation Analyzer .The primary outcome measure was a composite endpoint consisting of stroke or death within 90 days;≥50%stenosis in a artery association with clinical symptoms or cardioembolic source warranting anticoagu -lation.Results The composite end point occurred in 34 patients ( positive group ) and was not found in other 98 patients ( negative group ).The level of FIB was higher in positive group compared to negative group [(4.53 ±0.99) vs (3.05 ± 0.93)g/L, P<0.05].There was significant difference among low-risk, mederate-risk and high-risk groups in the levels of plasma FIB [(2.98 ±0.86) vs (3.54 ±1.47) vs (5.16 ±1.68)g/L, P<0.05].Spearman rank correlation coefficient test showed that the level of plasma FIB was positively correlated with ABCD 2 score (r=0.388, P<0.001).Cox regres-sion analysis showed that ABCD 2 score ≥4 and FIB≥3.5 g/L were significantly associated with the composite endpoint . Conclusion The level of plasma FIB significantly increase in TIA patients with positive composite endpoint , and is posi-tively correlated with ABCD2 score.Using the threshold value of 3.5 g/L for FIB, there was a trend toward FIB predicting outcome of these patients within 90 days after TIA .%目的:探讨血浆纤维蛋白原( FIB)检测在短暂性脑缺血发作( TIA)患者预后判断中的应用价值。方法选择急诊入院的132例TIA患者,均进行ABCD2评分,低危患者46例(0~3分),中危患者70例(4~5分),高危患者16例(6~7分)。采用全自动CA7000血凝仪检测TIA患者血浆FIB。患者预后采用复合终点事件来判断,包括在90 d内脑卒中或死亡、与症状相关≥50%大动脉狭窄或有心源性栓子需抗凝治疗。结果未发生复合终点事件98例(阴性组),发生复合终点事件34例(阳性组)。阳性组与阴性组患者血浆FIB水平分别为(4.53±0.99)、(3.05±0.93)g/L,两组比较,P<0.05。 ABCD2评分为低危、中危、高危患者血浆FIB水平分别为(2.98±0.86)、(3.54±1.47)、(5.16±1.68)g/L,三者间比较,P均<0.05。相关性分析结果显示,血浆FIB水平与 ABCD2评分呈正相关(r=0.388,P<0.001)。 Cox回归分析结果显示,ABCD2≥4分及血浆FIB≥3.5 g/L是TIA患者发生复合终点事件的预测因素(P均<0.05)。结论 TIA发生复合终点事件者血浆FIB水平明显升高,血浆FIB水平与ABCD2评分呈正相关。血浆FIB≥3.5 g/L时可有效判断90 d内TIA患者预后。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号